23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

Veradigm (MDRX) announced that its board of directors completed its previously announced review of strategic alternatives. “Throughout the ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

The health tech company formerly known as Allscripts, still reeling from failing to fix its financial reports, will have to ...

However, the Company did not receive any final proposals. "The Board undertook the review of strategic alternatives with the primary objective of maximizing stockholder value," stated Greg ...

The Board of Directors of 23andMe previously formed the Special Committee, which is comprised of independent directors, to review strategic alternatives that may be available to 23andMe. The Special ...

The analysis of strategic alternatives will include an assessment of various possible scenarios, including but not limited to raising additional capital or attracting a strategic investor ...

Review of Strategic Alternatives Throughout the review process, the Board, in collaboration with its financial and legal advisors, evaluated potential strategic opportunities, including a possible ...

Tripadvisor reached out to 19 parties and financial sponsors starting in December 2023 when it began considering strategic ...

The top management of the tour operator AB Novaturas (hereinafter referred to as Novaturas) has passed a decision to conduct an analysis of strategic alternatives. For this purpose, a contract was ...

After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on ...